title: Corticosteroids and prostate cancer: friend or foe?
authors.affiliation: Fox Chase Cancer Center, Temple Health, Philadelphia, PA, USA.
authors.forename: Daniel M
authors.initials: DM
authors.lastname: Geynisman
authors.affiliation: Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, USA.
authors.forename: Russell Z
authors.initials: RZ
authors.lastname: Szmulewitz
authors.affiliation: Fox Chase Cancer Center, Temple Health, Philadelphia, PA, USA. Electronic address: Elizabeth.Plimack@fccc.edu.
authors.forename: Elizabeth R
authors.initials: ER
authors.lastname: Plimack
mesh_terms: D000305:Adrenal Cortex Hormones / Q000097:blood*; D000736:Androstenes / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy*
chemical_list: D000305:Adrenal Cortex Hormones; D000736:Androstenes; D011241:Prednisone